These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4317029)

  • 41. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M; Zacara A; Woźniak S
    Gruzlica; 1968 Sep; 36(9):809-18. PubMed ID: 4882450
    [No Abstract]   [Full Text] [Related]  

  • 43. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 44. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M; Zachara A
    Gruzlica; 1968; 37(1):31-8. PubMed ID: 5720035
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemotherapy of tuberculosis.
    Lester W
    Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281
    [No Abstract]   [Full Text] [Related]  

  • 46. General survey of the clinical results of treatment of pulmonary tuberculosis with cycloserine in Turkey.
    Ozgen ZS
    Scand J Respir Dis Suppl; 1970; 71():189-91. PubMed ID: 5271984
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intravenous chemotherapy of pulmonary tuberculosis].
    Ivaniuta OM
    Vrach Delo; 1971 Jan; (1):84-7. PubMed ID: 4325153
    [No Abstract]   [Full Text] [Related]  

  • 48. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
    Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
    Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
    [No Abstract]   [Full Text] [Related]  

  • 49. [Drug therapy of urogenital tuberculosis].
    König K
    Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
    [No Abstract]   [Full Text] [Related]  

  • 50. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

  • 51. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical evaluation of intolerance to cycloserine.
    Baroni V; Foddai G; Lukinovich N; Pontiggia P
    Scand J Respir Dis Suppl; 1970; 71():217-9. PubMed ID: 4318440
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
    Tsukamura M
    Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
    [No Abstract]   [Full Text] [Related]  

  • 55. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 56. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of cycloserine in different chemotherapy combinations on chronic pulmonary tuberculosis.
    Susteric J
    Scand J Respir Dis Suppl; 1970; 71():159-61. PubMed ID: 5271978
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypocalcemia, hypomagnesemia and hypokalemia during chemotherapy of pulmonary tuberculosis.
    Vanasin B; Colmer M; Davis PJ
    Chest; 1972 May; 61(5):496-9. PubMed ID: 4340029
    [No Abstract]   [Full Text] [Related]  

  • 59. Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis.
    SOMNER AR; BRACE AA
    Tubercle; 1962 Dec; 43():345-60. PubMed ID: 13978199
    [No Abstract]   [Full Text] [Related]  

  • 60. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.